Search

Quick Filters

Compliance Status
Clear

Clinical Trials Data

Showing 2500 of 543136 entries
View as:

Advanced Analysis of the Carotid Phonoangiography and Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02049463 Org: User:
Start: 02/28/14 End: 02/29/16 Due: 02/28/17

CT Mar Technology and MR Mavric, Semac Sequence in Removing Artifacts of Orthopedic Metal Internal Fixation

Phase: N/A Priority: Normal
NCT ID: NCT04954963 Org: User:
Start: 12/01/19 End: 10/30/20 Due: 10/30/21

Study of the No-touch Saphenous Vein Graft

Phase: N/A Priority: Normal
NCT ID: NCT05757947 Org: User:
Start: 12/22/22 End: 12/22/25 Due: 12/22/26

Development of Diabetes in Adults With Cystic Fibrosis (CF)

Phase: N/A Priority: Normal
NCT ID: NCT03644199 Org: User:
Start: 03/30/11 End: 08/30/17 Due: 08/30/18

Diastology-Guided Management of Decompensated Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06131008 Org: User:
Start: 11/06/23 End: 07/31/24 Due: 07/31/25

Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management

Phase: N/A Priority: Normal
NCT ID: NCT03103919 Org: User:
Start: 03/16/17 End: 01/02/18 Due: 01/02/19

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne

Phase: N/A Priority: Normal
NCT ID: NCT06336603 Org: User:
Start: 11/15/23 End: 10/29/24 Due: 10/29/25

Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05305950 Org: User:
Start: 12/17/21 End: 12/31/26 Due: 12/31/27

Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03821792 Org: User:
Start: 07/22/19 End: 10/11/26 Due: 10/11/27

Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00849407 Org: User:
Start: 10/31/08 End: 12/31/20 Due: 12/31/21

Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01324336 Org: User:
Start: 07/31/11 End: 12/31/13 Due: 12/31/14

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01426880 Org: User:
Start: 08/31/11 End: 08/31/13 Due: 08/31/14

Bromocriptine and Insulin Sensitivity

Phase: N/A Priority: Normal
NCT ID: NCT02428946 Org: User:
Start: 10/31/14 End: 12/31/15 Due: 12/31/16

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00873756 Org: User:
Start: 05/31/09 End: 04/30/14 Due: 04/30/15

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Phase: N/A Priority: Normal
NCT ID: NCT01635972 Org: User:
Start: 06/30/12 End: 07/31/12 Due: 07/31/13

GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00398060 Org: User:
Start: 01/31/03 End: 03/31/07 Due: 03/31/08

A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02228785 Org: User:
Start: 05/31/94 End: - Due: -

Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00703079 Org: User:
Start: 01/31/97 End: 06/30/08 Due: 06/30/09

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00367094 Org: User:
Start: 07/31/06 End: - Due: -

AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD

Phase: N/A Priority: Normal
NCT ID: NCT05683379 Org: User:
Start: 12/20/22 End: 09/30/26 Due: 09/30/27

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.

Phase: N/A Priority: Normal
NCT ID: NCT02234089 Org: User:
Start: 09/30/14 End: 06/30/19 Due: 06/30/20

Improving Health Outcomes With Resource Facilitation

Phase: N/A Priority: Normal
NCT ID: NCT04462549 Org: User:
Start: 01/13/19 End: 12/31/22 Due: 12/31/23

Effect of Epidural Anesthesia on Blood Flow in Arterial Anastomosis of Free Flap

Phase: N/A Priority: Normal
NCT ID: NCT03330808 Org: User:
Start: 10/28/17 End: 05/05/20 Due: 05/05/21

Rifaximin Improves Gut Dysbiosis in Insulin Resistance and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03758144 Org: User:
Start: 11/01/18 End: 07/01/19 Due: 07/01/20

Study on Androgen Receptor and Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03383679 Org: User:
Start: 03/14/18 End: 07/20/22 Due: 07/20/23